课题基金 / 基金详情

Studies on the membrane complement inhibitors by use of reconstituted liposome membrane

Studies on the membrane complement inhibitors by use of reconstituted liposome membrane
利用重组脂质体膜研究膜补体抑制剂
批准号:
60570231
负责人:
OKADA Noriko
金额:
$1.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1985
资助国家:
日本
项目状态:
已结题
起止时间:
1985 至 1986

项目摘要

项目成果

OKADA Noriko的其他基金

相似基金

相关文献

中文摘要
翻译
将红细胞膜糖蛋白掺入人工合成的脂质体膜中,分析其对补体替代途径的影响。所得结果如下:1)来自豚鼠红细胞的糖蛋白(GP)抑制豚鼠补体的替代途径。2)对于抑制作用,糖蛋白需要存在于补体激活发生的同一膜上。3)膜糖蛋白已被证明可以抑制替代补体途径的扩增反应。4)通过蛋白酶- k处理,糖蛋白对脂质体膜的抑制能力被破坏。
英文摘要
Glycoproteins from erythrocyte membrane were incorporated into the artificially reconstituted liposome membranes and their effect on the alternative complement pathway was analysed. The results obteined are as follows;1) Glycoprotein(GP) from guinea pig erythrocytes inhibits the alternative pathway of guinea pig complement.2) For the inhibition, the glycoprotein was required to be present on the same membrane where complement activation occured.3) The membrane glycoprotein has been shown to inhibit the amplification reaction of the alternative complement pathway.4) The inhibitory capacity of the glycoprotein on the liposome membrane was aborished by proteinase-K treatment.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Okada,H.;Wakamiya,N.;Okada,N.;Kato,S.: Cancer Immunology and Immunotherapy.
冈田,H.;若宫,N.;冈田,N.;加藤,S.:癌症免疫学和免疫治疗。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okada,N.;Yasuda,T.;Okada,H.: Journal of Immunology. 134. 3316-3319 (1985)
冈田,N.;安田,T.;冈田,H.:免疫学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okada, H., Tanaka, H. and Okada, N.: Academic Press Inc.Increased immunogenicity of tumor cells by induction of complement-activating capacity of cell membrane: In Basic Mechanisms and Clinical Treatment of Tumor Metastasis. Chapter 14. 255-270, (1985)
Okada, H.、Tanaka, H. 和 Okada, N.:Academic Press Inc.通过诱导细胞膜的补体激活能力增加肿瘤细胞的免疫原性:肿瘤转移的基本机制和临床治疗。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 10 条
    Novel Complementary Peptides Control Inflammatory Responses
    • 批准号:
      22659081
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.51万
    • 财政年份:
      2010
    • 负责人:
      OKADA Noriko
    • 依托单位:
    Regulation of rejection against zenotransplantation by gene transfer of guinea pig species-specific complement regulatory molecules
    • 批准号:
      09670234
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1997
    • 负责人:
      OKADA Noriko
    • 依托单位:
    Development of transgenic animals of complement regulatory molecules.
    • 批准号:
      07557337
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.47万
    • 财政年份:
      1995
    • 负责人:
      OKADA Noriko
    • 依托单位:
    Studies on HRF 20, a novel membrane glycoprotein which restrict homologous complement reaction
    • 批准号:
      02670210
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $0.58万
    • 财政年份:
      1990
    • 负责人:
      OKADA Noriko
    • 依托单位:
    国内基金
    海外基金
    Microbubble-ZPDGFRβ/PFD/liposome通过靶向肝星状细胞改善肿瘤微环境抑制肝细胞癌复发转移的作用及机制研究
    • 批准号:
      82272000
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      杨秀华
    • 依托单位:
    基于Gd-HPDO3A@Liposome-Ga-68的PET/MR用于肝肿瘤增强显像及酸碱微环境检测